Over more than 10 years, Axia.Bio is pioneering the field of Pharmacoeconomics in Brazil.
Using our integrated knowledge of the intricate relationships between the market players, government and patient entities in the country, we are able to provide precise data and analysis.
Check out some of our recent publications.
Cost effectiveness of peginterferon alfa-2B combined with ribavirin for the treatment of chronic hepatitis C in Brazil
Consenso brasileiro do tratamento da fibromialgia / Brazilian consensus on the treatment of fibromyalgia
Contact us in Brazil or in the US
Axia.Bio has offices in São Paulo and Miami.
Validação do questionário de qualidade de vida (King's Health Questionnaire) em mulheres brasileiras com incontinência urinária / Validation of a quality of life questionnaire (King's Health Questionnaire) in Brazilian women with urinary incontinence
Find out more about the healthcare market in Brazil.